Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) EBT Margin (2016 - 2025)

Historic EBT Margin for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to 4.26%.

  • Sanara MedTech's EBT Margin rose 49500.0% to 4.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.89%, marking a year-over-year decrease of 35400.0%. This contributed to the annual value of 11.33% for FY2024, which is 45000.0% down from last year.
  • Latest data reveals that Sanara MedTech reported EBT Margin of 4.26% as of Q3 2025, which was up 49500.0% from 7.06% recorded in Q2 2025.
  • Sanara MedTech's 5-year EBT Margin high stood at 4.26% for Q3 2025, and its period low was 50.57% during Q4 2021.
  • In the last 5 years, Sanara MedTech's EBT Margin had a median value of 16.35% in 2021 and averaged 18.21%.
  • In the last 5 years, Sanara MedTech's EBT Margin tumbled by -327600bps in 2021 and then skyrocketed by 277100bps in 2023.
  • Sanara MedTech's EBT Margin (Quarter) stood at 50.57% in 2021, then skyrocketed by 46bps to 27.18% in 2022, then soared by 95bps to 1.48% in 2023, then plummeted by -1694bps to 26.62% in 2024, then surged by 116bps to 4.26% in 2025.
  • Its EBT Margin stands at 4.26% for Q3 2025, versus 7.06% for Q2 2025 and 14.48% for Q1 2025.